Infratil Limited

Kia ora tatou. I'm Jason Boyes, the Chief Executive of Infratil, and welcome to Infratil's annual results presentation for the year-ended 31 March 2026. I'm here with our CFO, Andy Carroll. Morning, Andy. Morning. And together, we're going to run through the annual results presentation that was released to the ASX and the NZX this morning. You can also find our annual report and a whole bunch of other supporting information in that release. So without further ado... This is an overview of the company that all of you will hopefully be familiar with. We're very proud of the strong track record that we're showing on the right-hand side there. Very strong growth over many periods and remarkable over such a long period since inception. If we then switch to having a quick look at the portfolio, this is a snapshot of the portfolio as at 31 March. We had some farewells and a welcome during the year. During the year, we sold Retire Australia, Infantile Property, and 40 South, our Towers business. We also sold Manawa Energy into Contact Energy. As we progressed our median term target that we described last year of divesting up to $1 billion of assets over the median term, one welcomes the Anytime Radiology, which was established during the year, our Tally Radiology business that we spun out of our ANZ Radiology businesses. I'll talk about that a little bit more later on. So quickly to the highlights. We delivered growth in what were very volatile markets. I'll let Andy talk to the numbers in a second, but quickly focus on the two main drivers of growth, CDC and Long Road. Both have their growth being accelerated by the massive build-out of AI infrastructure globally. CDC is now a global scale data center operator with more than a gigawatt of contracted capacity and a strong growth outlook. That's underpinned by its new Moody's BAA2 public credit rating, which shows what a differentiated platform CDC continues to be for us. Long Road Energy is also accelerating, delivering strong earnings growth during the year. and with a strong growth outlook as well that I'll talk about in a second. Our largest New Zealand businesses were resilient with Wellington Airport and 1NZ delivering their guidance and positive EBITDAF growth despite challenging market conditions. It wasn't all rosy though with Gurren Energy and Galileo and renewable energy development having a difficult year and our New Zealand radiology business dealing with a weak local economy. I'll talk about both of those in a second. We're on track to achieve that $1 billion divestment target I talked about with 600 sold and the sales process underway for QSCAN. And we also announced a credit rating, Standard & Poor's BBB+, which transforms our access to debt markets, which is perfect timing given the strong growth we're seeing from CBC and Long Road in particular. Lastly, strong ESG performance across the portfolio is translating into higher ratings, as we've put out here, which exposes us to more ESG-oriented investors around the world. Over to you, Andy, on the financial highlights.

Thanks, Jason. Yes, a couple of quick call-outs, which I'll touch on in a little more detail later on. So 989 million proportionate operational EBITDAFs, so almost a billion in the top half of guidance. $2.7 billion of proportionate capex. You know, we've talked about that in the past, that investment driving future earnings growth. And then in terms of total asset value, that's up 13%. There's a few other stats there, but I'll touch on those a little later. Thanks, Jason.

Thanks, Andy. Back to you later. And let's go through some of the portfolio companies. And, of course, starting with the big one, CDC. A strong operating performance from CBC achieving their guidance, a nearly 20% uplift in EBITDAF during the year. Large uplifts in built operating capacity with 350 of the 450 megawatts that were under construction at the start of the year completing construction. CapEx was up. $400 million to $2.1 billion completing those builds, but also getting started on further builds with 572 megawatts under construction at year end. The big news, of course, was the 555 megawatt customer contract announced on 5 May, just after the 31 March cutoff, but important to mention, lifting our contracted capacity to over a gigawatt as we've got here. together with existing contracts that are expected to come billing as construction completes, as shown in this graph on the right-hand side, which is the same as the one we showed on the fifth. CDC has good funding flexibility to deliver that growth and more, as CDC's CFO outlined on the call we had then. This is supported by the credit rating I mentioned before, which gives it access to multiple debt capital markets at a much lower cost than if it weren't rated correctly. The first step in that program is the hybrid AMTN wholesale bond program or bond issuance announced by CDC yesterday. Looking ahead, the FY27 EBITDAF guidance is that big jump we showed in March and again on the 5th to $680 to $720 million. This exceeds our guidance last year that we were doubling the $330 million delivered in FY25. We're maintaining that $1 billion EBITDA for FY28F that we talked about in May, more than doubling again last year's earnings over the next two years. And we're on track to double again to $2 billion in FY30 once the contracted capacity is fully deployed over FY29. So remarkable growth, really, doubling earnings every two years, and that all contracted already. Lots of work to do, but the contracted side is in good shape. CAPEX guidance is understandably increasing also, double last year's $2.1 billion at the top end, excluding land because that is lumpy. And lastly, but importantly, we see further growth potential from here with unprecedented demand continuing for further small, medium and large scale deployments that have the potential to accelerate the business even further towards the back end of this decade and beyond. The team are currently... Contract discussions are progressing well for more signings, I should say, in the first half of this financial year and beyond as well. And finally, the team are actively progressing a gigawatt or more of extensions to their growth pipeline, which as at 31 March was, say, a bit over a gigawatt, which you can see on the next slide here as well, just on the right-hand side. That's unchanged from what we showed in May. CDC is well positioned to continue to capture... outsize growth as what we see and what we've been saying for some time is quite a differentiated platform with strong access to funding, driving off strong contracted earnings and premium customer mix with capability and pipeline enabling it to scale efficiently and continue to deliver strong returns for Infratel as the shareholder. Moving then to Longroad. Probably the most new news in this section of growth businesses anyway. It also delivered its guidance, lifting EBITDA for giant 170% over the year to this 121 million we are showing here. But importantly, future growth is strong too with another two gigawatts under construction and coming online over FY27 and 28. and a further 1.7 gigawatts expected to commence construction this year so those two together 3.7 gigawatts will more than double the capacity in operation at the beginning of this year 3.5 gigawatts all put into construction over the next last year in this year so another business looking to double every two years if you like because its growth is so strong we also report and track The stat we're talking about on the right-hand side, OPCO run rate EBITDAF, which is a little like CBC's contracted earnings or EBITDAF that I just talked about, that $2 billion I just talked about for them. So how we do that is shown on the right-hand side. It's worth just stepping through it. At the end of FY26, those earnings were $367 million in line with the guidance we set at the start of the year as well. So what that does is we take reported EBITDAF and then we add back the contracted annualised earnings of the projects that are under construction in that year, which you're seeing that 144 on the right. And we also add back the development expenses, which are really investment in new projects, and the corporate overheads to give a view of value of just the operating projects or what we call the OPCO, the operating company. If you wanted to convert that into a valuation, we see listed comps trading in the kind of 13 to 15 times that number or that number looking a year ahead because the business is growing so quickly. And if you use about 60% gearing or eight times EBITDAF for leverage, remembering the revenues contracted for 30 years or more with minimal maintenance capex, that should give you a good sense of the equity value pretty close to the independent valuation that we're putting out there. Lastly, you might recall that law changes in the US last year meant that tax credits for solar projects would expire by 2030, but your projects had to be qualified by later this year, actually. We're confirming on the bottom of this slide that we've qualified more than six gigawatts of projects now to support our development targets out to 2030. And remember that battery storage credits, which apply to half the capex effectively of the projects these days, remain accessible through to 2037, so a much longer runway on that support from the federal government under the current settings. These tax credits, what they do is they effectively reduce US renewable energy power prices, but renewable energy is still competitive without them. So we believe you can look through them for a lot of purposes. The expiry, though, of the solar tax credits should mean a big build program out to 2030 as developers and power buyers look to take advantage of them before they expire. So now, looking ahead. The biggest news here is that Longroad has materially increased its target development cadence for the next four years from 1.5 gigawatts per annum to 2 gigawatts per annum on average, a 33% increase. That's supported by what we've talked about for a long time now, the robust demand for electricity, supported by AI and broader electrification and decarbonisation still going on in the US. It's also supported by the good work the team has done, tax qualifying that more than six gigawatts of projects I talked about. And also new news today, a super large project Long Road acquired in April. It's a 2.8 gigawatt solar and storage project, so nearly as big as our entire operating fleet today in one project, and importantly has a PPA in place. That project on its own would deliver, I should say, the uptick in development cadence we have guided to. So there's potential to grow even faster, I think. The other key things to know about this project are it's expected to come online calendar year 28-29, so towards the back end of the decade. And also that is contingent on two regulatory approvals that Long Road is confident can be obtained. Based on similar projects that have recently been approved and the clear need for the power, we expect to be able to update on progress on those approvals over the year. What does that all mean? If you took the average earnings from our projects, that uptick sees on the right-hand side that graph, long road targeting $1 billion of OPCO run rate EBITDA, that run rate earnings measure I mentioned earlier, by the end of the decade. Double what those earnings will be at the end of this year, that doubling in two years that I've mentioned. I've also talked to multiples. You could use those to backsell the equity value of what I just talked about. Or another way, we've guided in the past to about $300 million US of net present value value creation for every one and a half gigawatts of projects, because that's what we were trying to do every year. So $300 million a year. And I'd say that's conservative. If you lift that by 33%, the number of gigawatts you're delivering, then... the NPV is bigger as well. So another $100 million of NPV creation per annum is kind of what we're talking about. Or by the same metric, if you looked at our new project, that's kind of two years of development, or $600 million US of NPV, just to give you a rough sense of it. A significant acceleration, I would say, compared to where we were before. But that's not all. At the bottom here, we're revealing that Long Road has also been actively progressing its own data centre strategy to develop, at the moment, four-plus gigawatts of grid-connected data centres co-located with Long Road's solar and storage projects. We can develop the powered shell to have more value creation, either alone or with partners, or simply sell that land as powered land to data centre developers. Either way, you're able to accelerate Long Road's own core energy development pipeline, developing the renewable energy for those facilities. We're not ready to value this pipeline. It's not an independent valuation, but it's a very logical and interesting opportunity that we intend to pursue. So lastly to guidance. Regarding a modest uplift this year, $120 to $135 million, that's because a lot of the construction that's underway will complete towards the back end of this financial year and actually into FY28. but also because of increased development expenses really in line with that acceleration of development business. I just talked about that increased development cadence. That's taken another $20 million off that. But you can see the impact of that strong development addition, the extra 1.67 gigawatts we see coming under construction this year coming into the OPCO run rate EBITDA at the bottom, lifting that to nearly $500 million over the year, so $120 million increase. Ampertil has agreed to provide an additional $300 million of equity funding to support this acceleration which would be deployed over the next two years and we see very strong returns from that obviously. I think that's it on longer, maybe over to you Andy. Oh no, two more. This is a good spot to put this, because the US has been incredibly strong, but as I mentioned in the opening, elsewhere it's been a little tricky. Juran has done well in Southeast Asia, progressing its projects, but really the big focus is on this key approval that we're waiting for, for Project Banda, its own very large project. The government-to-government discussions appear to be producing positively, which are needed to facilitate that approval. But it's fair to say that's taking longer than we hoped, and we hope to be able to update on that over the half. Turning to Europe, that has been a difficult market as well. Really the prolonged effect of the Ukraine war, the pressing demand for new electricity there means that the markets have reached a kind of mature stage and values for earlier stage projects have reduced markedly, making our target returns more difficult to achieve. That's led to a strategy reset over the last half to focus on projects that are nearer term, so taking off the longer term projects, and the ones that can take the business to more material scale, which would be more resilient business over the near term as well, and we're showing the targeted state to that business by 2030. That resulted in some write-downs and write-offs, which I mentioned here, which are not particularly big or material from an infrastructure perspective, but were clearly not what we hoped for or what the team hoped for from the business. They've got a good plan in place, I think, to get the business back to growth, and we'll be reporting on that over the half as well. Maybe not you, Andy. Yeah.

Thanks, Jason. One, the team is continuing to deliver well in challenging market conditions. EBITDAF up $4 million on the prior period. We promised a stronger second half, and that's what the team has delivered. A few call-outs on the slide. So mobile revenues continuing to perform well. And you'll also see an uplift in handset and other sales. which it does talk to the effectiveness of one wallet as a retention tool, so that program is going well. E.ON Fibre had its first full year of operation with EBITDAF of $65 million, and of particular note secured a material undersea contract. contract with a hyperscaler. Now there's work to be done there so you don't expect revenues to turn up for 12 months or so and there is some capex and other spend associated with delivery of that contract over the next 12 months. In terms of metrics that people regularly ask us about, free cash flow and dividends, you'll see that they have both doubled over the last 12 months. And that graph is on the next slide. In terms of outlook, my commentary has been largely unchanged for the last 18 months, so soft economic conditions, challenging competitive environment, and limited immigration, which all contributes to a pretty challenging operating environment The team is conscious of careful financial management in those circumstances. So, you know, focused revenue growth in particular areas and you'll see that there are price increases that have been applied to both mobile and fixed in April. We're also keeping a close eye on costs while pushing on a number of key strategic programs of work. You'll see, you know, to the end of cost control, we have over 50 AI solutions working across the business now, delivering cost savings, productivity benefits, and customer experience benefits. The IT program continues to track to plan. Moving to guidance, there is an uplift in EBITDAF guidance relative to the previous year. CAPEX is unchanged. I've noted some of the E.ON fibre-related spend. And our medium term EBITDA margin and CAPEX intensity targets remain unchanged. Thanks, Jason. Back to you.

Nice one, Andy. Back to you in a minute, actually, but let me talk through the rest of the portfolio, starting with Wellington Airport. Their results are already public, but from our perspective... a resilient performance given the ongoing aircraft capacity issues last year and the weak economic environment domestically. Good growth in international, though, that you can see here. The outlook for the next year is relatively flat with aircraft back, but fuel crisis affecting capacity, of course. We'll have to revisit that guidance number if the crisis continues to be protracted, but the team are doing a great job managing them with the guidance so far. Sensible capex to continuing en route development with the runway now able to accommodate long-haul flights to Asia, Matt tells me. I'm looking forward to that. Next is CAO Data. Quickly on then, that's our London Data Centre business. A strong year, actually, doubling its contracted capacity so that I think actually it's nearly sold out at the moment. So you can see why CAO acquired a prime London data centre site that we've talked about here, which would be attractive to multiple hyperscalers in that location, and is progressing that as well as its existing Manchester site. So its growth ahead looks good, just at a much smaller scale than CDC, of course, from a shareholder perspective. Lastly, I think, is our healthcare businesses. But not least at all, so diagnostic imaging, of course. It's been a difficult year, as I said, at the top for our New Zealand business, with EBITDAF slightly down over the period, reflecting cost and competition pressures. The excellent team there, though, is implementing a performance improvement plan, as we've said there, to return the business to growth in its early days, and we'll report back at the half on that. In Australia, on the other hand, Qscan has had an excellent year. delivering double-digit growth from a range of initiatives executed pretty well. The sales process for that business is ongoing, and we stick to our date on that in the half as well. And then finally, Anytime Radiology, the newest addition to the portfolio, is now up and running after being spun out of our ANZ businesses. It's a pure play-tally radiology business, which is a subsector of radiology that's growing faster than traditional ones. It's small now, but we think more likely to be successful and attractive in this standalone format. Back to you, Andy. Thank you.

I think I've touched on a number of these metrics already. So operational EBITDAF in the top half of guidance, key drivers, CDC and Long Road, as we had foreshadowed. I didn't touch much on infertile investment, but that alongside that proportion of capital expenditure are the ingredients for future earnings growth and shareholder value accretion. So I think those are the key numbers to touch on there. Independent valuations, just touching on a few of the movements there. So CDC is the largest one. Unsurprisingly, and part of that increase does reflect the additional investment that we made into CBC through the period. If I touch on some of the pinks, so 1NZ is down 320 odd million, and that broadly reflects that reduced growth outlook that we've seen in the New Zealand economy. So moderated growth outlook, and I think now the midpoint of that independent valuation does align with market consensus. Galileo is weaker for reasons that Jason has outlined, so some write-downs and also some of those early stage projects, less value attributed to that pipeline. And RHC also reduced, so underperformance relative to guidance, so moderated growth outlook from a different base. So those are a few things just to call out on the independent evaluation slide. Thank you. This is exactly as we foreshadowed at the half year, so 13.65 cents. There are no imputation credits attached and we will continue to run the DRP with a 2% discount. Funding and liquidity. I will spend a bit more time on this slide because there are some changes here. Our inaugural S&P BBB Plus credit rating, we announced that in late December and that is proving material in terms of reduced funding costs, broader access to capital sources and improved funding terms. So we have some brand new banking arrangements in May, that's one example of that, with cost savings and improved borrowing terms realised. Today we're lodging our first capital bonds PDS which should also enhance funding flexibility and you can expect to see further work from us to diversify funding sources over the balance of this financial year. Just to give you a sense of some of the cost saving benefits, so we see savings in the order of 10 million per annum in interest costs in the medium term. And last but not least on the slide, liquidity, $1.1 billion of available liquidity at 31 March, and clearly we've enhanced that with the partial sale of our contact stake recently. Guidance. We've talked a lot about growth this year, so proportionate operational EBITDAF up materially 20% odds in this year, midpoint 1350 and that largely reflects the CDC uplift which we've talked to you about previously. Proportionate development expenditure, that's up a touch. Corporate cost guidance. Now, we have broken that out separately. We did have that sitting within proportionate operational EBITDAF. So all of the component parts here are unchanged, but there is a different dynamic that drives corporate costs. That's largely related to the individual share price as opposed to proportional operational EBITDAF, which talks to the earnings performance of the investments. We think it is helpful to break out those component parts so you can better understand the individual drivers. If you want to reassemble the guidance fruit salad, you're very welcome to. So yes, corporate costs called out separately. And then proportionate capex guidance range, that's up 50%. Again, largely reflecting that CDC effect, which we have previously guided on. And I think I'm back to you now. Thanks, Jason.

Great. Thanks, Andy. Is there a slide? Ah, yes, I see you've switched them around. Great to see that billion of proportional operating even if you've reassembled a fruit salad, as you say. I think we're touching over that, which is great to see that finally happening. I want to touch on two things before wrapping up and going to questions. First, sustainability highlights. As I mentioned at the top, strong progress has been made across our portfolio and portfolio companies, some of which are mentioned here, resulting in the improved ratings, which we'll continue to work on to improve. I think the key metric to watch is our SBTI target, which really hinges on the scoping work CDC is doing to set its own SBTI target. Now that its first report under the new Australian reporting regime is completion, So that's the one I would focus on from now. And then the second thing is our median term strategic objectives that we set at the result last year, wasn't it? On the first, we set a target of a billion of divestments and completed 600, as I said, with Qscan underway. We see the potential for another billion plus of divestments over the medium term as well of investments we think are unlikely to scale under our ownership. And as we said last year, we expect to be reinvesting those into growth or new businesses. On the second objective, this is on track with improved distributions from 1MZ and a stronger outlook for CDC over the longer term. I think this year we needed a little under 90 million to cover all of the dividends being balanced. Andy, so this is in sight. On the third, frankly, we're reassessing this a little bit. CDC and Long Road have accelerated materially and set a very high bar for new ideas, which we've continued to look at. But now our focus is on interesting adjacent opportunities, like Long Road's own data center ideas, for example. In the near term, assessing these adjacent ideas is a higher priority, and we'll update on this and the strategic objectives, I think, at our investor day, which I think is in September this year. That's probably the right place for that discussion. Lastly, the share register. While progress has been made, this is still an important work on for the reasons we outlined last year. So let me wrap up. Growth this year has been excellent, but we continue to position the portfolio for further step changes in growth ahead. CDC is facing this once-in-a-lifetime opportunity to develop AI infrastructure globally, or I mean at a globally relevant scale, with strong demand and its deep capability pipeline and funding flexibility to continue to accelerate. Long Road also, right, setting materially high development targets its own path to the Billion Club, a billion of run rate EBITDA by the end of the decade, backed by the new, very large-scale project that's been acquired, subject to regulatory approvals, of course. But we continue to develop other materially, potentially material growth opportunities, right, including Longo's data centre options, which we've revealed today, and don't forget Groen's Vander project. As Andy outlined, Invertel has significant flexibility to support that growth, especially with the new credit rating. And we continue to focus on lifting operational performance across the portfolio, as shown by 1NZ and QSCAN's strong performance this year, and actually Wellington Airport, I would say, and improvement plans in place for the New Zealand diagnostic imaging business and Galileo. I feel like we've navigated the noise of 2025, and while there's plenty of noise still about in the world, we're as positive as ever about the opportunities and options for the portfolio ahead. So thank you to all the teams in the portfolio companies, all the teams at Morrison, and all our customers and stakeholders for the progress we've made this year. We might go to questions.

Thank you. If you wish to ask a question, please press star 1 on your telephone and wait for your name to be announced. If you wish to cancel your request, please press star then 2. If you're using a speakerphone, please pick up the handset to ask your question. The first question today comes from Eric Choi from Baron Joey.

Please go ahead. Thank you. Morning, Jason and Andy. Could I please ask one question on Long Road and one on CDC? Just on Long Road and on the data centre strategy, I was wondering if I could confirm, A, what the book or market value of that land is, B, that the IE hasn't included that land value in the valuation you said, included the project so I should have included the land value as well and see that land value we should be thinking of that as maybe the floor I'm just referencing your annual report I think you made a comment you want to bring power and DC expertise together and I was just wondering does that mean you can leverage CDC can long road DCs maybe even generate CDC type level returns which would make the build cases more compelling than the land one sorry I'll put it there yeah I think you've

Put all the pieces together there. Well, Eric, I don't think the land will be in the valuation, or if it is, it won't be particularly material. The land that we're generally acquiring, it's not metro or anything, and it's very competitively available. I think the overall expenditure on this initiative would be in the low single-digit millions, and that's really just because you're converting stuff we already have or buying the land next door. and what they do is put in an application to take load out of the grid rather than put it in to give you a sense of the activity but there's so much alignment i think between this stage of development that longer does and what cdc already does in australia that it made sense i think to recycle all that capability and see what progress could be made and breakdown surprised how much they've managed to progress over six months so none of that none of the potential PV of those being turned into powered land or being sold as powered land is in the independent valuation yet. I think there is an interesting potential for CDC and Long Road to work together and send them as teams. having a building, a relationship. But even without that, there can be other partners in the US if that doesn't really work for CDC to develop it or that they could partner with. There are small development teams around. I think Long Road and the shareholder group are still figuring out what the best way to take advantage of this opportunity is. Clearly there's a lot more present value to be got through developing the data center as well and leasing it out and sort of stacking that on top of the value you're generating from the energy. If you look at what CBC earns and turn that into US dollars and maybe take a bit off, it's pretty interesting, right? We make $70,000 of EBITDA per megawatt roughly from a long-road energy project. That's pretty much what our average is saying. you would be making more like a million dollars of EBITDA on a data centre if you added that to it. So pretty interesting kind of step up in the NPV that's potentially available to Long Road or its partners. That's how we're thinking about it.

That's very useful. Thanks. And then just a quick one on CDC. I'm just trying to do our own analysis on this. where that IE value actually could go once the 500 megawatts in any first half, 27 millions of factors. So my question is, does the IE reference contracted EBITDA multiples at all? And if so, is the benchmarking peer set in the mid to high teens? And the piece of information we're missing is the capex that would be required to fulfill the existing one gigawatt pass of contracted contracts.

Yeah, I understand the question. The independent valuer does reference a wide range of comps, lifted comps, but also the contracted earnings statistic you referred to, which I think is probably the most common way of eyeballing the valuation of these businesses. It would be in the mid to high teens, and of course you've seen businesses trade at a 20% in the past as well on a contracted earnings basis. You have to adjust that for the CapEx, of course, which is why you've got your next question. So hopefully that answers the first one. On the CapEx, we gave the guidance in May, which we're holding here, which is this kind of mid-teens per megawatt X land, that you can use that. What you're probably missing is how much of that is already being spent or built, I'm guessing. And if you think of the 572 we're building now, I think we've spent about a quarter of the capex for that amount of the megawatts. So hopefully that'll get you pretty close to, I guess, a net debt number at the back end and a capex number. I don't know if you had a quick follow-up to that. Make sure I got your question.

No, that was excellent. I'll re-poll to give everyone else a chance. Thank you very much, Jason.

Thank you. The next question comes from Wade Gardner from Craig's Investment Partners. Please go ahead.

Hi there. Hi. I'm glad that Eric asked that around the percentage of completion. I was sort of working off, you know, 3.2 to 4.2 million divided by, say, 15 megawatt would imply that it's about 50% complete, but you're saying it's more like a quarter complete. Yeah. That's of the 570 underway. Oh, an extent. Yeah, at the end of March. Extension to that, once that's completed, you'll have roughly about 1.2 gigs of which is sold. about one. If you did another big contract and therefore we're starting to talk about developing the pipeline, what's the timeframe to sort of, you know, if we push through today, how long could you, you know, call it 100 megawatt data center?

Yeah. So we have 100 megawatt of sort of blocks available still in our pipeline. You can sort of see that right and they would be I talked in the voiceover about sort of towards the back end of the decade I think is what you're asking is when could that turn up in earnings when where is the real potential upside I think this year is largely done right 28 is capacity for upside but then more 29 30 onwards is the way to think about it way just that I think that's what you're asking

Yeah, I'm just sort of, I guess if I look at the 1.6 gigs of pipeline. you know, if we were to include the development gains of that in our valuation, you know, a big part of that is understanding when those development gains arrive. You know, are we talking five years? Are we talking 10 years?

Yeah. Yeah. So I would say nothing much in the next two years and then from 29 onwards is kind of what I'm saying and bigger chunks from 2030 onwards. OK. Yeah.

Um... One, previous guidance has included, I think last year, 25 million rides to SpaceX exclusivity and AI acceleration. Is there anything in the guidance for this year?

Some of those elements are implicit in guidance. So SpaceX exclusivity has expired, but the service ongoing isn't free. And it continues to be, you know, so we talked about SpaceX AI and there was property moves, so the property move is complete. There is ongoing AI spend still at the point where it's investment ahead of the return, albeit that, you know, some of the returns are absolutely in-year, but it's growing momentum. So there are still elements of that in their weight, yes.

Okay. And just finally also on one, can you provide any update on whether the new IT stack program, how that's looking? Yes.

So we talked at the half year about prepaid being complete. We are now well through the post-paid migration, and that is material, but it is tracking to plan, and that is, you know, there's phase two of broadly a three-phase program. We've talked about three years, so we're, you know, we're approaching the, you know, crunch time for phase two. Okay.

Thank you. That's all from me. That's right. Thank you. The next question comes from Suraj Nibani from Citi. Please go ahead.

Thank you. Just a couple of quick ones from me. Firstly, just a follow-up on Eric's question on the valuation assumptions for CDC. Is it fair to say that the contracted capacity that was announced earlier this month is yet to flow through into the independent valuation?

That's correct. It came after 31 March, yes.

Yeah, okay. All right. And then I guess just to answer to Eric's question, Jason, on CapEx and, you know, on the 572. So that mid-teens number, is that on a 572 megawatt basis or should we think of it on an ICT sort of contract?

Sorry, great clarification. That's the ICT number.

Yeah. Yeah. Okay. Understood. Yeah. Understood. Thank you. Yeah, and then the second question was, again, not surprisingly on a long road. I'm just interested to understand, you know, this data center strategy, you know, a bit more. Let's see, you know, how much capacity, let's see how close it is and, you know, is there further capacity to increase that over time? In terms of data centres, yes, demand is growing strongly, but there's a lot of supply as well. So how do you think about that?

Yeah, that's a great question. And I think the key is to understand these are grid-connected. They're co-located with often projects we were already planning to build. They just happen to be in good places for data centres as well. So we have certainly a long-term view on the value of those sites as energy sites. On the data center side in terms of timing, long-runners talking to, like a lot of people in the market, pretty much all the hyperscalers, they're all focused on like a 29 onwards type delivery date. And so some early studies have come in saying some of the projects could hit that timeline. Some of them are saying later. So it's still reasonably early on to when we could say definitively that a project could hit a 2930 delivery date, which is kind of the zone where customers are interested just now. So maybe bear with us over the half, and we'll have the team down here in September at the investor day to get a good sense of that. But it's still... reasonably long dated. I think to hit that in the US at the moment, there's almost always a bridge to grid solution. So the bundled energy and data center side of things is getting, I think, quite a lot of traction. And then if you zoom out from a shareholder perspective of long road, it just creates a different potential bias set for this business if you roll out two or three years. It's actually your being able to generate your own, in some ways your own demand for your power projects through the data center side of your business rather than necessarily relying on, you know, kind of utility RFPs and things like that. So Zoom Forward, potentially a much more stable sort of development business than we've enjoyed over the last few years.

I'll just ask one last question on the corporate cost raise. You know, that's obviously significantly higher and the development spend as well compared to last year. How are you thinking about on a go-forward basis? And firstly, what's driving that? Is it just increased activity across the various businesses?

I think the corporate cost is about the same as last year. in the development expenses where we had another 20. That's really just increased team size, increased cadence on more megawatts than we were doing last year. And if there's an increase on the corporate side, it would be the element of that that we can't automatically charge to the project. So, yeah, I think it goes hand in hand with that. If you're asking should that happen every year, I don't think so unless we're also increasing delivery cadence as well.

Understood. Thank you. Sure, sir. Thank you. The next question comes from Grant Swanepoel from Chardon. Please go ahead.

Morning. Can you hear me? Yeah. Morning, Grant. Good morning. Just on the long road, I might have missed this, but your stake's gone up to 42.5%, and I see that's from the extra equity you've put in. Is there a read-through on the implied valuation of the extra equity?

Not yet, Grant. Not yet, no.

So that is linked to you over-tipping in the extra equity share. That's right, yeah.

But we haven't... We haven't contributed the cash. We haven't contributed the cash yet.

Yeah, yeah, I saw that. Yeah, saw that. The cadence step-up of 1.5 to 2 gigawatts per annum on long road, is that factored into independent valuations yet? Because it seems to have gone up very little, even though the WAC did go up and offset some of it. It just seems the long road valuation has just stalled for a while.

Yeah. No, it isn't. A lot of the headwind in the long road valuation itself in US dollar terms is rising interest rates, frankly, so you've had a reasonable amount of discount rate expansion. So the business said what it said it was going to do, it just was worth less in that interest rate environment effectively. But no, this is really, because we didn't buy the new project until April, all the stuff is not in that 31 March valuation yet.

Thanks. This extra $1 billion of divestments you're talking about now, does that include the $495 you've just realized through the contact sale? No. And then, you know, what's your less in contact is over $9 million. Is that just the extra billion you're talking about here? No.

No, it doesn't include the 495, and we don't talk about exactly which business that we're choosing to divest for all sorts of reasons, including disruption to the businesses. We had in mind a target like this already to give you a sense of it. So I think if you go through the portfolio, you can pretty easily see which investments aren't able to scale. It's definitely more than the context rate, which could actually scale. So no, it's not just that.

Thanks. And just a final question, just wanted to see, you did answer the questions from Wade and Barry and Jerry, but the contracts you're talking about in first half of 27, just try again with that feel of what the quantum could be. Just in terms of the buyers, when do they need you to start delivering megawatts that allows you to really scale again with another big contract?

I mean, as Greg described, I think I know what you mean. As Greg described, there's great demand now, you know, sort of outstripped the available supply tomorrow. But for a while I've been talking about, you know, this delivery of 2930. You can look at peers and see where they're signing contracts for deliveries. Clearly that zone for lighting things up, 2930, is the zone that people are most interested in now, exactly the same as Long Road is here in, in the US. So if you're thinking about the kind of next set of contracts, think they're good contracts, you know, there's a kind of a broad range of the small, medium, large, it's but they're very lumpy. So why we're sort of a little bit vague is, well, one moves, you know, then people think they're disappointed. So they're lumpy, but they're all ranges of sizes. The demand is good. And, you know, we hope to have an update in the half on exactly what that kind of near-term contracting that Greg alluded to in May is. And then longer term, I think it's sort of that end of the decade and beyond is probably more realistic at this stage in terms of further growth.

That's great. Thanks so much for answering those questions. Great.

Thanks, Matt. Thank you. The next question comes from Ben Crozier from Forsyth Bar. Please go ahead. Hey, Ben.

Morning, guys. Just first one on Long Road. You just called out this project you acquired. It still needs federal approval on the land lease extension. I think some of the other projects, renewable projects across the US have run into a bit of problems on federal land. Is that what Long Road's experience is and what gives you the confidence that you'll get the approval for that?

Yeah, exactly. That was a big part of due diligence in the board and shareholder discussions. The thing that gives us confidence here is it's in a region with a counterparty that's had good success recently on getting these approvals through for all sorts of various reasons, but also because the demand is very strong. So without that track record, we'd be very sceptical, but that recent track record is what gave us confidence.

And then just on the project sort of completing later this year, is that sort of a delay in development that is sort of time to time table that you would have expected maybe 12, 18 months ago, noting that sort of completions are below your, you know, one and a half gigawatt target of the last sort of 12, 18 months?

Yeah. We guide the one and a half on getting into operations. rather than completions, but I know what you're saying. I don't think any of those came in super late, but they are a longer build time. I was sort of surprised as it was coming through as well that there was so much really in the next financial year. But there's nothing material going on in terms of build times or delays and starts, if that's what you're asking.

Yeah. No, that's some good clarity. Thanks. And maybe one just last one on 1MZ, like, I know you talked to some of these AI improvements haven't shown up in cost savings overall, but are you able to give out or pull out a couple of examples of projects where you have seen, you know, deployed AI and sort of what cost savings you've seen, you know, in those specific projects to date? Because I know sort of OPEX, the standard of revenue sort of increased this year. And if we look at going to that 35% margin target, we'll have to come down, you know, quite a bit over the next few years.

Yeah, I'm not going to get into too many specifics, but, I mean, we have got a good sense of What's cost avoided? What's cost saved? And some of the projects that are more visible from a public perspective, you will see 1NZ is referenced publicly. For example, when it comes to false calls to the call centre, AI agents collecting relevant data, response times reducing by 80% as a consequence. And those are sort of early stage projects that then you can think differently about how you resource them and there might be medium term and longer term cost savings. But I think the good news is the breadth of deployment and the nature of the benefits that are being realised does give us confidence that there is a medium term and longer term cost material cost saving in the mix.

That's all for me.

Thank you. The next question comes from Ben Cura from Shakespeare. Please go ahead. Hi Ben, your line is open if you'd like to ask your question. I might move on to the next question. It's from Stephen Hudson from Macquarie Securities. Please go ahead. See you then.

Hi, Jason. Hey, Andy. Just a couple from me. Just firstly on Long Road, you mentioned in your annual report the Thousand Mile project is being developed for Meta. I just wondered if you could flesh that out, particularly in light of the four gig, you know, new VC projects development strategy you know whether or not there's opportunities there at all.

Yeah I think the relationships are definitely proving helpful as we from selling electrons to showing land as well so having an existing relationship with meta that's not the only project we've built for them and they've been tax equity on another project as well is helpful but that project I believe we bought with the PPA so yeah it was well before this data strategy was lit up but I think That's helpful. We have other projects that we sell to Microsoft and then there are others where Google has been in and around them. So it's really those, extending those relationships from the power side to the kind of infrastructure side is part of the strategy for sure.

Okay, thanks. And just on the billion dollars of further asset sales, can we get some sort of colour on what you're thinking is around rationalising the 13-company portfolio there. As you said, we can do the maths, but what's your latest thinking in terms of complexity and the price and AV gap?

Yeah. We still believe, I think, Andy, that asking people at our current scale to analyse both data centres' energy offshore as well and say healthcare is probably too hard And so hence the Q-scan sale. So we would see it tightening down. But it's not just that. I think there are some earlier stage investments in energy and data centres, for example, where the path to material scale is not super clear. And so there are things we're considering here. If you roll forward, as I was saying, we'll talk about this a bit more at Invest today because we're still learning and developing our thinking. Maybe... two to three markets focused in and around AI infrastructure, so energy, building and up, could be kind of more coherent from a capital markets perspective. I think also take advantages of the capability we've got and the great starts we've got across the platform. and also lead to still an interesting growth profile, just at our current scale. I think we haven't changed our spots. You know, Infratool has made its track record on moving in and out of sectors as they became more or less attractive. And we would still reserve the right to continue to do that over time. But for a variety of reasons, a kind of more focused strategy over the next period feels good to us and something we're more focused on than spreading out again just now.

That's useful. Thanks, Jason. Just a couple of quick ones. Just back to Long Road. I think somebody else asked a question around your shareholding. Are there any advantages to you going higher in terms of your existing shareholding and, you know, in the egg and in ZS shares? going to be participating in the current equity raise?

There aren't any yet, so it's just more share of the good growth we see ahead. I think for those other two investors, they have their own kind of portfolio-related reasons for whether they're participating or not, which has given us the opportunity this time to get a bigger share of the future growth we see. Going forward, who knows, it'll be a question we'll be asking them as well.

Okay, and one last quick one, sorry. The one gigawatt pipeline extension that you referred to on CDC, did you say that the current contract discussions that are taking place and that you're likely to update us on over the first half of this financial year will support that sort of 3.9 gigawatt ultimate pipeline, or were you saying that it's actually beyond that timeframe?

No, I think they're quite separate things. I think these contracts we talked about we've been working on for a long period of time and we already have the land and everything for those kind of near-term ones. We're talking about longer-dated contracting discussions that I'm telling people, you know, realistically back into the decade and into the 2030s is when they would light up. So topping up the land pipeline for those sorts of target dates. which you kind of obviously have to do having accelerated so quickly in terms of contracted over the last month.

If you'd want reasonable certainty on your contract discussions before you go on, you know, the land sport an extra gauge, essentially, is what you're saying?

Oh, no, no, no, no. I think we're seeing enough from demand to justify actively progressing that now, is what I'm saying. You know, you put down a deposit and pay later in a lot of instances, and the amount you spend on the land is pretty immaterial relative to the overall build cost of it. So we're signalling you should see that, I think, 1.6 gigawatts of future pipeline we showed at 31 March, you should expect that to continue to extend. over the year.

That's useful. Thanks, Jason. Great. Okay, the next question is from Paul Mason from E&P. Okay. Please go ahead.

Hey, guys, this is two from me. First one, just on your credit ratings, I was just wondering if you could give us some comments on like, what your plans around managing those are? Like, you know, are you aiming to keep them stable through time for the headstock and for CDC, or is there scope here to maybe look at a lower rating and more gearing now that you're in the rating system or a higher rating count? What's your general plan?

Any questions? Andy?

Well, I think both public ratings are green-spinking news, so I think you can expect us to continue to support those. And we both have... a number of tools available to us to support the current ratings and grow liquidity. In both cases, we're looking at capital notes with equity credits, divestments, broadening our funding profile. So I think you can expect steady as she goes from both of us for the foreseeable future. Yep.

Okay, great. And the second one was just on the cow data and air cloud deal that you guys mentioned. Can you just give us a bit of colour of how it came together and also just the structuring? Is it similar to what you did with Furnace where you've got some additional credit comfort? Yeah.

Yeah, I think that particular customer has been growing strongly in the UK, particularly as the government's pushed their kind of sovereign AI efforts. So they participated in a lot of the kind of white papers and worked with the government on that. And so I believe the relationship was built out of working together on those things. The credit profile is obviously different from hyperscale. And so, yeah, there's slightly different technology than was used in Firmis but trying to get to the same point where you're able to start using money from the customer to start building things and effectively raising the equity content in the build and then sort of ongoing credit support as well to give you comfort you know, ahead that the rent's going to be paid and interest and all those things will be met. So, yeah, interesting to see how that technology is evolving all around the world. This is another iteration of it that we've seen and there's others we've heard of as well. But, yeah, that's exactly what's going on. Thank you.

Okay, I think we have one more question, do we? Yes, thank you. Nick Harris from Malkin Financial. Great. Please come ahead.

Hi, Nick. There we go. Hi Jason, how are you going? Thank you. Thank you for the questions. So two, one was just on the long roads, potentially long-term data center builds. From what you said on the delivery dates, it sort of feels to me like it's more traditional CDC KO-style colo rather than potentially neocloud builds. Obviously, the rest of those NCPs are scrambling onto secure energy. Yeah. I'm just trying to understand what the theoretical counterparty might look like so I can get a feel for the theoretical funding envelope.

Yeah, yeah. It's actually both in the kind of near cloud, the kind of more institutional end because of the The debt requirements, even the project finance requirements for your energy, right, does narrow the aperture a bit. And then traditional hydroscale, which has been quite interesting to see how the U.S. market has developed its view on how to finance kind of lower investment credit rated or sub-investment credit rated neoclubs or model builds. So kind of wrap technology from maybe the chip provider, their own credit support like we were just talking about with Paul there, plenty of innovation that's resulting in investment-grade credit structures for counterparties that I think a year ago would have been almost unimaginable for the market. So hopefully that gives you a sense that there's actually a broader set than just the big hyperscalers that I think could back one of these projects.

Yeah, and a lot of those NCPs are obviously backed by the hyperscalers as well.

Yeah, yeah. Yeah.

Cool. And just my second question was on Gurren's project, Vanda. I just wanted to make sure I understood correctly. The sort of slippage you're seeing at the moment, as I understand it, is more governments taking their time, as governments tend to do, as opposed to any specific roadblocks you may need to overcome?

Yeah, that's a good question, Andy.

Yes, that's right. So the key milestone we are waiting on is Indonesian export licence, and that does involve conversations between Singapore and Indonesia. That is the key milestone. We've ticked off a number of the stepping stones that are precursors to that, but that export approval is taking longer, so it is moving to the right.

Yeah, and I think the context has... for a new Indonesia government that's come in since these projects were started, is there enough benefit, right, for Indonesia that they're seeing? So that's the kind of conversations that are going on. So not so much to do with our project, but that kind of broader context, particularly in light of the energy crisis at the moment, I think, as well.

That's great. Thanks, Jason and Andy.

No worries. Thanks to the Christians. Okay. Well, let's wrap it up there. Thank you very much for your attention today. Hopefully see you out on the road trip we're about to do. If not, we'll talk to you again around investing. Have a good day.